Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT03310294
Eligibility Criteria:
Inclusion Criteria:
* Healthy free-living men and women aged 18 to 65 years-old.
* History of recurrent HL (2 - 4 episodes) after exposure to sunlight in the previous 12 months.
* Fitzpatrick skin type 1 to 4 (appendix 1 of the study protocol).
* No presence of HL lesions at time of recruitment, including baseline.
* Agreement to adhere to the prescribed list of dietary recommendations provided at the start of the study (appendix 3 of the study protocol).
* Women of child-bearing potential are required to use adequate birth protection during the study.
* Sign and date the ICF to and to comply with study procedures
Exclusion Criteria:
* Presence of acute/terminal disease.
* Intolerance for milk protein or lactose.
* Treatment with acyclovir or other medication believed to interfere with immune responses at the time of the study.
* Participation in any herpes UV reactivation study within the previous three months.
* Pregnancy or lactation.
* Any condition (e.g. schizophrenia, psychosis, major depression or mental deficiency) or major co-morbidity that the study investigator thinks might compromise the person's ability to comply with the requirements of the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03310294
Study Brief:
Protocol Section:
NCT03310294